奥精医疗：部分高管拟减持股份

Core Viewpoint - The company, Aojing Medical (688613.SH), announced plans for share reduction by key executives due to personal funding needs, which may impact investor sentiment and stock performance [1] Summary by Relevant Sections Share Reduction Plans - The company's general manager, Mr. Qiu Zhiye, plans to reduce his holdings by up to 95,000 shares, representing no more than 0.07% of the total share capital [1] - The financial officer, Ms. Wang Ling, intends to reduce her holdings by up to 70,312 shares, accounting for no more than 0.05% of the total share capital [1] - Vice general managers, Mr. Song Tianxi and Mr. Tian Guofeng, plan to reduce their holdings by up to 50,000 shares (0.04%) and 37,500 shares (0.03%), respectively [1] Implementation Timeline - The reduction plans will be executed within three months starting from 15 trading days after the announcement [1] - The total number of shares reduced through centralized bidding will not exceed 1% of the company's total shares over any continuous 90-day period [1] Adjustments and Pricing - Any changes in share capital due to stock dividends, capital reserve transfers, or other corporate actions will lead to corresponding adjustments in the planned reduction amounts [1] - The reduction price will be determined based on market conditions and the method of transaction [1]